[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100103921":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":32,"collaborators":34,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"University of California, Davis","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Lavjay Butani, M.D.","PRINCIPAL_INVESTIGATOR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":7},"Lavjay Butani","CONTACT","(916) 734-8118",[18],{"facility":19,"status":20,"city":21,"state":22,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":7},"UC Davis Medical Center","RECRUITING","Sacramento","California","95817","United States","US",{"type":27,"coordinates":28},"Point",[29,30],-121.4944,38.58157,{"lat":30,"lon":29},{"type":33,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[35],{"name":36,"class":37},"Ministry of Higher Education, Science and Technology, Solvenia","OTHER_GOV","100103921","register-for-pediatric-patients-with-antiphospholipid-syndrome-aps-european-project-extended-internationally-study-100103921",false,"NCT00616317","Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study","APS","Inclusion Criteria:\n\n* 18 years of age or younger at the onset of disease\n* Presence of Vascular Thrombosis\n* UC Davis patient\n* Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma\n\nExclusion Criteria:\n\n* Infants born to mothers with APS\n* Infants with congenital thrombophilia","ALL","1 Minute","18 Years",{"count":49,"type":50},50,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.",[54],"Antiphospholipid Syndrome",[54],"2025-12-03",{"date":58,"type":59},"2025-12-05","ACTUAL",{"date":61,"type":7},"2006-09",{"date":63,"type":50},"2040-01",{"name":5,"class":6},1]